Comparison between Amar Remedies IPO and Sasken Communication Technologies IPO.
Amar Remedies IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Sasken Communication Technologies IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
| Amar Remedies IPO | Sasken Communication Technologies IPO | |
|---|---|---|
| Logo | ||
| Issue Category | Mainboard | Mainboard |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | ||
| Registrar | ||
| Market Maker | ||
| DRHP | ||
| RHP | ||
| Final Prospectus | Final Prospectus ![]() | Final Prospectus ![]() |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Amar Remedies IPO is whereas the issue size of the Sasken Communication Technologies IPO is . The final issue price of Amar Remedies IPO is ₹28.00 per share and of Sasken Communication Technologies IPO is ₹260.00 per share.
| Amar Remedies IPO | Sasken Communication Technologies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹24.00 per share | ₹230.00 per share |
| Issue Price (Upper) | ₹28.00 per share | ₹260.00 per share |
| Issue Price (Final) | ₹28.00 per share | ₹260.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 1,50,00,000 shares | 50,00,000 shares |
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 1,50,00,000 shares | 50,00,000 shares |
| Issue Size Total (Amount) |
Amar Remedies IPO opens on Aug 25, 2005, while Sasken Communication Technologies IPO opens on Aug 11, 2005. The closing date of Amar Remedies IPO and Sasken Communication Technologies IPO is Aug 31, 2005, and Aug 17, 2005, respectively.
Amar Remedies IPO P/E ratio is , as compared to Sasken Communication Technologies IPO P/E ratio of .
In the Amar Remedies IPO Retail Individual Investors (RII) are offered 52,50,000 shares while in Sasken Communication Technologies IPO retail investors are offered 52,50,000 shares. Qualified Institutional Buyers (QIB) are offered 75,00,000 shares in Amar Remedies IPO and 27,00,000 shares in Sasken Communication Technologies IPO.
| Amar Remedies IPO | Sasken Communication Technologies IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | ||
| QIB | 75,00,000 shares | 27,00,000 shares |
| NII | 22,50,000 shares | 4,50,000 shares |
| RII | 52,50,000 shares | 13,50,000 shares |
| Employee | 5,00,000 shares | |
| Others | ||
| Total | 1,50,00,000 shares | 50,00,000 shares |
Amar Remedies IPO subscribed in total, whereas Sasken Communication Technologies IPO subscribed .